Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06541210 · ClinicalTrials.gov registry record · NA

Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men

A NA study of Prostate Carcinoma, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT06541210 is a NA study of Prostate Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06541210, a NA study of Prostate Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Community Health Service

Study Locations (1)

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-05-04
Est. Completion 2027-09-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06541210

The ClinicalTrials.gov registry entry for NCT06541210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT06541210 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06541210 about?

NCT06541210 is a clinical study titled "Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men". This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab...

What is the current status of trial NCT06541210?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-05-04. Estimated completion is 2027-09-30.

What conditions does trial NCT06541210 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT06541210?

The interventions under investigation include: Questionnaire Administration (OTHER), Community Health Service (OTHER).

Who is sponsoring clinical trial NCT06541210?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06541210 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.